SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Santaris Pharma A/S Advances New Cholesterol-Lowering Drug, SPC5001 Inhibiting Exciting New Target PCSK9, Into Phase 1 Clinical Trials for the Treatment of High Cholesterol